Ultomiris (ravulizumab)
pCPA File Number:
22625
Negotiation Status:
Active Negotiation
Indication(s):
Neuromyelitis optica spectrum disorder (NMOSD)
Sponsor/Manufacturer:
Alexion Pharma GmbH
CDA-AMC Project Number:
SR0785-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded:
Not Applicable